Inventor · disambiguated record
Sara Hamon
Also filed as: HAMON SARA · HAMON SARA C
4 granted patents·7 pending applications·0 citations·filing 2018–2025
57Inventor score
Top patents by PatentIndex Score
11 records- 0169US12116622B2Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGFREGENERON PHARMA·Filed 2021·Granted Oct 15, 2024·0 cites·28 claims
- 0268US2024029897A1Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VEGFREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0362US11519020B2Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGFREGENERON PHARMA·Filed 2018·Granted Dec 6, 2022·0 cites·16 claims
- 0457US2023416349A1Methods Of Identifying And Evaluating Cat Allergy Gene Signatures In A Subject By Determining A Stratified Score Based On Gene ExpressionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0556US2023340601A1Transcriptome Analysis For Treating InflammationREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0656US2025255516A1Gait analysis systemREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0754US11769597B2Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGFREGENERON PHARMA·Filed 2018·Granted Sep 26, 2023·0 cites·20 claims
- 0849US12310717B2Gait analysis systemREGENERON PHARMA·Filed 2021·Granted May 27, 2025·0 cites·19 claims
- 0945US2024248301A1Systems and methods for mobile and static biometric movement trackingREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1042US2023340101A1Methods for treating or preventing allergic asthma by administering an il-33 antagonist and/or an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2020·Application pending·0 cites
- 1139US2022199245A1Systems and methods for signal based feature analysis to determine clinical outcomesREGENERON PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sara Hamon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →